L-arginine: Supplement tested on fit, athletic men shows no advantage
One of the most recent, popular supplements for athletes looking to boost performance comes in the form of a naturally-occurring amino acid called L-arginine.
The reason for its popularity is twofold says Scott Forbes, a doctoral student in exercise physiology. "First, L-arginine is a precursor for nitric oxide that is known to improve blood flow, which in turn may aid the delivery of important nutrients to working muscles and assist with metabolic waste product removal. Secondly, L-arginine has been shown to increase growth hormone levels in the blood."
The benefits of growth hormone are diverse, including increasing the use of fat as a fuel as well as insulin and insulin-growth factor-1 (IGF-1) levels. However, most of the research conducted on L-arginine has been in a clinical setting and the benefits for physically active individuals are not as established. In some cases they are conflicting.
"One of the reasons for this is that the amount an individual has to consume has not been clearly established and this information is rarely provided by the manufacturers of such products," explains Forbes, a doctoral student in exercise physiology.
For Forbes it was a theory worth testing and he wanted to test two different L-arginine doses on healthy, athletic men the group most likely to purchase this readily-available supplement.
"L-arginine is interesting for a few reasons," says Forbes. "It can increase growth hormone response, and so can increase muscle mass. Also it has an impact on insulin, which is another anabolic hormone. A recent hot topic has been about nitric oxide as a vasodilator. The theory is that if you can vasodilate your arteries you can potentially enhance blood flow to the muscles and enhance nutrient delivery and waste product removal."
L-arginine is also often prescribed for older adults with cardiovascular disease, endothelial dysfunction or hypertension for its vasodilation properties and is rarely studied in younger, more vigorous populations.
For this study, Forbes recruited 14, active, physically fit men (age: 25±5yrs; weight: 78.0±8.5kg; height: 179.4±4.7cm), who were free of nutritional supplements, to examine a low and high dose of oral L-arginine on blood L-arginine, markers of nitric oxide, growth hormone, insulin, and insulin-like growth factor-1. In the double-blind, randomized, placebo-controlled study participants were first pre-screened, completing a one-day food record which was analyzed for carbohydrates, protein and fat consumption and caloric intake, then required to follow a modified diet to regulate intake of food and water prior to being dosed with L-arginine.
"After a 10-hour overnight fast, and no breakfast, we gave them a different dose of L-arginine either .075 g per kilogram of body mass for the low dose, .15 g per kg of body mass for the high dose, or a placebo," says Forbes.
Blood samples were drawn with the athlete at rest, every half hour for three hours after the L-arginine or placebo dose. The reason explains Forbes, is that "Previous studies show that two hours after consumption L-arginine tends to reach baseline again."
What Forbes found was that in healthy, young, physically active males the two different doses significantly elevated L-arginine concentrations in the blood at rest, and both a low dose and a high dose were equally effective in doing so, but neither dose promoted a significant increase in nitric oxide, growth hormone, insulin, or insulin-like growth factor-1.
So, according to the study, it appears that L-arginine's impact depends on one's current health status: the more healthy and athletic the person, the less they'll benefit from it.
Now that he's established how L-arginine impacts the fit, young body at rest, he's embarked on two more studies one with strength-trained athletes and one with aerobically-trained athletes cyclists in this case to look at the impacts of L-arginine on the body during exercise. "This time we're looking at the effects of supplements under two extremes: aerobic and strength exercise.
"There's a lot of money in nutritional supplements," he adds. "The industry might not be too happy when they see the results at rest, but who knows, it may be different with exercise."
Forbes has completed both of the exercise studies and hopes to publish the results in the near future.
Provided by
University of Alberta
-
Study finds popular muscle-boosting supplement does not increase blood flow
Aug 10, 2011 |
not rated yet |
0
-
New study suggests dietary supplement can protect against pre-eclampsia
May 20, 2011 |
not rated yet |
0
-
Discovery could help fight human obesity
Feb 04, 2009 |
not rated yet |
0
-
'Moonlighting' enzyme unravels arginine paradox
Nov 13, 2011 |
not rated yet |
0
-
Dietary supplement speeds silver cyclists
Mar 23, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Flesh-eating disease victim gets prosthetic hands
(AP)—A woman who lost both hands, her left leg and right foot after contracting a flesh-eating disease has been fitted with prosthetic hands.
Other
3 hours ago |
not rated yet |
0
Illinois Senate approves medical marijuana bill
(AP)—Medical marijuana use in Illinois is now in Gov. Pat Quinn's hands after the state Senate approved legislation.
Other
14 hours ago |
5 / 5 (1) |
0
Nigerian court jails two over killer teething drug
A Nigerian court on Friday sentenced two officials from a pharmaceutical company to seven years in prison over the sale of an adulterated teething drug which killed 84 babies in 2008.
Other
14 hours ago |
not rated yet |
0
Many patients would switch doc to cut health care costs
(HealthDay)—Many Americans feel that keeping out-of-pocket health care costs is more important than staying with the same primary care physician.
Other
16 hours ago |
not rated yet |
0
Cultural attitudes impede organ donations in China
(AP)—China is phasing out its reliance on executed prisoners for donated organs, but an architect of the country's transplant system said Friday that ingrained cultural attitudes are impeding the rise of ...
Other
19 hours ago |
not rated yet |
0
AIDS science at 30: 'Cure' now part of lexicon
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Temporal processing in the olfactory system
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
Melon focus headband turns to Kickstarter for rollout plans
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Study identifies new approach to improving treatment for MS and other conditions
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...